Article
A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care
2025-10-23
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> exome (ES) or genome (GS) sequencing are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of GS continues to be debated. <h4>Methods</h4> This prospective randomized trial involving all Belgian Human Genetics centers compared the standard of care (SoC) - combining ES and chromosomal microarray anal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da183899-0d52-59d4-8212-f8ca3301e231
- DOI
- 10.1101/2025.10.18.25328208
